GL1X · GenesisL1 explorer

MolNFT v1 · #105878 · protein

Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate

4RI5 · Tyrosine-protein phosphatase non-receptor type 3: “Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate”. X-ray diffraction, 1 ligand (VN4), 5 pockets (best druggability 0.74). MolNFT v1 #105878 on GenesisL1…

PDB
4RI5
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 3
EC
3.1.3.48
UniProt
P26045
Ligands
VN4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48)protein28437% helix, 24% strandP26045

Ligands and binding sites

  • VN4 · oxido(dioxo)vanadium · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18240.740.7984GOL, VN4
21520.490.7719empty
31030.420.7718empty
4500.400.8214empty
5530.270.7416empty

Interfaces

1 interface between chains.

  • A–B · 466 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4RI5 · Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate · the same entry in another collection · chain B against B, TM-score 1.00
  • P26045 · AlphaFold monomer V2.0 prediction for tyrosine-protein phosphatase non-receptor type 3… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.